Key Points
Philips reports May 6 with $0.24 EPS and $4.49B revenue estimates.
Company beat EPS in 67% of recent quarters despite current weakness.
Meyka AI rates PHG B grade reflecting neutral sector positioning.
Investors should monitor segment performance and margin stability closely.
Koninklijke Philips N.V. (PHG) will report first-quarter earnings on May 6, 2026 after market close. The Dutch healthcare technology company faces analyst expectations of $0.24 EPS and $4.49 billion in revenue. These estimates represent a significant pullback from recent quarters, signaling potential headwinds in the medical devices sector. With the stock trading at $26.24 and a market cap of $24.96 billion, investors are watching closely to see if Philips can maintain profitability amid ongoing market pressures. Meyka AI rates PHG with a grade of B, reflecting neutral positioning in the healthcare sector.
What Analysts Expect From PHG Earnings
Analysts project Philips will deliver modest earnings this quarter. The consensus $0.24 EPS estimate marks a sharp decline from the $0.70 EPS reported in the February quarter and the $0.41 EPS from July 2025. Revenue expectations of $4.49 billion also suggest contraction compared to recent quarters.
Historical Earnings Trend
Philips has shown volatile earnings performance over the past year. The company beat EPS estimates in two of the last three quarters, delivering $0.70 versus $0.504 expected in February and $0.41 versus $0.317 expected in July. However, the current estimate of $0.24 represents the lowest projection in recent memory, suggesting analysts expect significant pressure on profitability.
Revenue Estimates and Context
The $4.49 billion revenue estimate falls below the $5.99 billion reported in February and the $5.11 billion from July. This pattern indicates seasonal weakness or potential market challenges. Philips operates across three segments: Diagnosis & Treatment, Connected Care, and Personal Health. Weakness in any segment could pressure overall results.
Historical Performance and Beat/Miss Pattern
Examining Philips’ recent earnings track record reveals important patterns for predicting this quarter’s outcome. The company has demonstrated mixed results, beating on EPS in two consecutive quarters but facing revenue pressures.
Recent Quarter Comparisons
In February 2026, Philips delivered $0.70 EPS against a $0.504 estimate, a 39% beat. Revenue came in at $5.99 billion versus $5.03 billion expected, another strong beat. July 2025 showed similar strength with $0.41 EPS beating $0.317 expected. However, May 2025 results were more modest, with $0.27 EPS beating $0.14 expected but revenue of $4.65 billion slightly missing the $4.56 billion estimate.
Prediction for May 2026
Based on this pattern, Philips has a 67% beat rate on EPS over the past year. However, the current $0.24 estimate is unusually low, suggesting analysts may be positioning conservatively. If Philips delivers even modest operational performance, a beat is possible. Watch for management commentary on cost controls and segment performance.
Key Metrics and What to Watch
Several financial metrics will determine whether Philips meets or exceeds expectations. Investors should focus on operational efficiency, cash flow generation, and segment-level performance during the earnings call.
Profitability and Margins
Philips’ net profit margin stands at 5.02% trailing twelve months, relatively thin for a healthcare company. Operating margin of 7.98% provides some cushion. The company must demonstrate it can maintain these margins despite revenue pressures. Watch for gross margin trends, which currently sit at 45.18%. Any compression here signals pricing pressure or unfavorable product mix.
Cash Flow and Debt Management
Operating cash flow per share of $1.17 and free cash flow per share of $0.78 are critical. The company carries a debt-to-equity ratio of 0.74, manageable but elevated. With $2.90 per share in cash, Philips has flexibility but limited room for major acquisitions. Management should address capital allocation priorities and any refinancing plans.
Segment Performance
The Diagnosis & Treatment segment, which includes imaging systems, typically drives profitability. Connected Care and Personal Health segments face competitive pressures. Investors should listen for guidance on each segment’s growth trajectory and margin expansion opportunities.
Meyka AI Grade and Investment Implications
Meyka AI rates PHG with a grade of B, reflecting neutral positioning relative to sector benchmarks. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The rating suggests Philips is neither a compelling buy nor a clear sell at current levels.
What the B Grade Means
The B rating indicates Philips scores at the median for healthcare companies. The company shows adequate profitability and cash generation but faces headwinds in growth. Return on equity of 8.21% trails many peers, while the PE ratio of 24.18 suggests the market prices in modest growth expectations. The grade reflects balanced risk-reward positioning.
Analyst Consensus and Valuation
Four analysts rate Philips as Hold, with no buy or sell recommendations. This consensus aligns with the neutral B grade. The stock trades at 1.20x sales and 1.97x book value, reasonable valuations for a mature healthcare company. However, the 3.68% dividend yield provides income support, making the stock attractive for yield-focused investors despite modest growth prospects. These grades are not guaranteed and we are not financial advisors.
Final Thoughts
Philips reports May 6 earnings with modest expectations: $0.24 EPS and $4.49 billion revenue, down from recent quarters. The company’s 67% historical beat rate suggests potential upside. Investors should monitor segment performance, margins, and 2026 guidance. With a neutral rating and Hold consensus, the stock appears fairly valued for income investors but lacks near-term catalysts. The earnings call will reveal whether weakness is temporary or reflects deeper market challenges.
FAQs
What EPS and revenue does Philips need to beat estimates?
Analysts expect $0.24 EPS and $4.49B revenue. Based on Philips’ 67% beat rate, the company likely needs to deliver $0.25+ EPS and $4.55B+ revenue to exceed expectations. Any beat would support the stock near-term.
How does the $0.24 EPS estimate compare to recent quarters?
The $0.24 estimate is significantly lower than February’s $0.70 EPS and July’s $0.41 EPS. This represents the lowest projection in recent memory, suggesting analysts expect material pressure on profitability this quarter.
What should investors watch during the earnings call?
Focus on segment performance (Diagnosis & Treatment, Connected Care, Personal Health), gross margin trends, free cash flow generation, and management guidance for 2026. These metrics will determine if weakness is temporary or structural.
What does Meyka AI’s B grade mean for PHG investors?
The B grade indicates neutral positioning. Philips scores at sector median with adequate profitability but modest growth. The 3.68% dividend yield appeals to income investors, but limited upside catalysts suggest a Hold stance.
Is Philips likely to beat or miss earnings estimates?
Philips has beaten EPS in two of three recent quarters. However, the unusually low $0.24 estimate suggests conservative analyst positioning. A beat is possible if operational performance remains stable, but revenue pressure is real.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Earnings estimates are analyst projections and not guarantees of actual results. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask Meyka Analyst about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)